Clinical Trial: The Use of Domperidone for Gastroparesis

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: Monitoring Study for the Use of Gastroparesis for Patient Who Have Failed Standard Therapy

Brief Summary: The purpose of this study is to determine whether domperidone can be used safely and effectively for patient with gastroparesis.

Detailed Summary: Individuals who have been diagnosed with gastroparesis and have failed at least one standard therapy will be offered to trial domperidone as a possible remedy to their condition. Patients on the medication will be expected to to be followed by the physician at 3 months, 6 months 12months, and then annually while on the medication. Any change or significant adverse reaction to the medication or in their condition should be reported immediately to their physician.
Sponsor: Allegiance Health

Current Primary Outcome: Improved Gastric motility [ Time Frame: 3 months ]

Patients will have improved gastric motility within three months of begining domperidone therpy


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Allegiance Health

Dates:
Date Received: February 3, 2010
Date Started: March 2010
Date Completion: March 2014
Last Updated: March 18, 2013
Last Verified: March 2013